# Frontida BioPharm Inc – FDA Inspection, Jul 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/frontida-biopharm-inc/be6ada2f-716c-4ddd-8b36-f7d3b7cd65b3
Source feed: FDA_Inspections

> FDA inspection 1279864 of Frontida BioPharm Inc, July 22, 2025. Classification: No Action Indicated (NAI). 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279864
- Company Name: Frontida BioPharm Inc
- Inspection Date: 2025-07-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Tobacco Post-Market Activities
- Product Type: Tobacco
- Center: Tobacco Products
- Office Name: Center for Tobacco Products
- Citation Count: 0

## Related Documents

- FDA Inspection 1316756 - 2026-04-02
- FDA Inspection 1280570 - 2025-07-22
- [FDA Inspection 1226606 - 2023-12-07](https://www.keypedia.com/records/fda_inspections/frontida-biopharm-inc/9b8055f0-3548-413c-a40b-5814226a9434)
- [FDA Inspection 1097023 - 2019-07-19](https://www.keypedia.com/records/fda_inspections/frontida-biopharm-inc/19fa9164-4fb0-41e4-9013-e9731116e4ad)
- FDA Inspection 1030391 - 2017-07-20

## Related Officers

- [Company Rep](https://www.keypedia.com/people/devon-jenkins/cf47975b-987a-4672-9a37-135a4401b198)

Company: https://www.keypedia.com/companies/frontida-biopharm-inc/dc8190f9-0e13-4160-a611-dcf664f43b09

Office: https://www.keypedia.com/offices/center-for-tobacco-products/65f73cae-ef6f-4e9f-a311-a111daa67374